PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.86%
Positive revenue growth while AVGO is negative. John Neff might see a notable competitive edge here.
-2.73%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-8.56%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-8.56%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
11.72%
Net income growth above 1.5x AVGO's 3.47%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
13.33%
EPS growth above 1.5x AVGO's 5.88%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
11.36%
Diluted EPS growth above 1.5x AVGO's 6.25%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.33%
Share count expansion well above AVGO's 0.25%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
-0.16%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-0.33%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-46.66%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-57.02%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
216.43%
10Y revenue/share CAGR under 50% of AVGO's 713.08%. Michael Burry would suspect a lasting competitive disadvantage.
187.87%
5Y revenue/share CAGR similar to AVGO's 172.99%. Walter Schloss might see both companies benefiting from the same mid-term trends.
116.94%
3Y revenue/share CAGR above 1.5x AVGO's 44.71%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
911.25%
10Y OCF/share CAGR under 50% of AVGO's 4076.10%. Michael Burry would worry about a persistent underperformance in cash creation.
186.18%
Below 50% of AVGO's 383.91%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
69.97%
3Y OCF/share CAGR under 50% of AVGO's 149.93%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
1678.73%
Below 50% of AVGO's 19032.54%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
888.08%
5Y net income/share CAGR above 1.5x AVGO's 373.85%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
344.99%
3Y net income/share CAGR similar to AVGO's 338.73%. Walter Schloss would attribute it to shared growth factors or demand patterns.
240.19%
Below 50% of AVGO's 1418.19%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
109.17%
Below 50% of AVGO's 335.99%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
88.86%
3Y equity/share CAGR above 1.5x AVGO's 9.87%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
100.01%
Below 50% of AVGO's 809.51%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
52.81%
Below 50% of AVGO's 398.43%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
33.51%
AR growth well above AVGO's 1.58%. Michael Burry fears inflated revenue or higher default risk in the near future.
30.00%
Inventory growth well above AVGO's 5.51%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
6.02%
Positive asset growth while AVGO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
7.38%
Positive BV/share change while AVGO is negative. John Neff sees a clear edge over a competitor losing equity.
-0.55%
We’re deleveraging while AVGO stands at 0.05%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
4.13%
R&D growth drastically higher vs. AVGO's 7.30%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
8.86%
We expand SG&A while AVGO cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.